TADALAFIL

TADALAFIL was reported 101027 times

TADALAFIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 125 0.6983
1 MALIGNANT MELANOMA STAGE II 75 0.4573
2 MALIGNANT MELANOMA STAGE I 97 0.3566
3 DEVICE WIRELESS COMMUNICATION ISSUE 77 0.2973
4 MALIGNANT MELANOMA STAGE III 60 0.2956
5 CATHETER SITE VESICLES 56 0.2872
6 CATHETER SITE PRURITUS 248 0.2825
7 CATHETER SITE RASH 118 0.2611
8 CATHETER MANAGEMENT 232 0.2581
9 DEVICE MAINTENANCE ISSUE 151 0.2568
10 LIBIDO DISORDER 311 0.2390
11 CATHETER SITE IRRITATION 79 0.2372
12 PULMONARY HYPERTENSIVE CRISIS 62 0.2288
13 TRANSPLANT EVALUATION 115 0.2264
14 MALIGNANT MELANOMA IN SITU 277 0.2236
15 WALKING DISTANCE TEST ABNORMAL 84 0.2148
16 INFUSION SITE INFECTION 499 0.2145
17 CATHETER SITE DISCHARGE 238 0.2117
18 PULMONARY ARTERIAL HYPERTENSION 2897 0.1997
19 CONGENITAL HIATUS HERNIA 44 0.1930
20 INFUSION SITE DISCHARGE 324 0.1846
21 CARDIAC FAILURE HIGH OUTPUT 44 0.1826
22 PULMONARY ARTERIAL PRESSURE INCREASED 297 0.1822
23 CATHETER SITE ERYTHEMA 387 0.1807
24 PULMONARY ARTERIAL PRESSURE ABNORMAL 51 0.1771
25 PULMONARY VENO-OCCLUSIVE DISEASE 117 0.1671
26 RIGHT VENTRICULAR FAILURE 1108 0.1579
27 SPONTANEOUS PENILE ERECTION 96 0.1546
28 INFUSION SITE WARMTH 187 0.1525
29 OXYGEN CONSUMPTION INCREASED 362 0.1513
30 VASCULAR DEVICE OCCLUSION 50 0.1475
31 INFUSION SITE IRRITATION 188 0.1463
32 INFUSION SITE HAEMORRHAGE 479 0.1455
33 INFUSION SITE OEDEMA 121 0.1447
34 INFUSION SITE PAIN 1829 0.1418
35 INFUSION SITE INDURATION 207 0.1396
36 INFUSION SITE VESICLES 72 0.1369
37 CATHETER SITE SWELLING 128 0.1368
38 CATHETER SITE INFLAMMATION 75 0.1332
39 INFUSION SITE CELLULITIS 70 0.1326
40 COUNTERFEIT DRUG ADMINISTERED 45 0.1308
41 BENIGN PROSTATIC HYPERPLASIA 673 0.1302
42 CATHETER SITE PAIN 334 0.1286
43 INFUSION SITE ERYTHEMA 1073 0.1271
44 INFUSION SITE INFLAMMATION 85 0.1204
45 INFUSION SITE ABSCESS 60 0.1190
46 DEVICE INFUSION ISSUE 293 0.1180
47 CATHETER SITE EXTRAVASATION 44 0.1103
48 VASCULAR DEVICE INFECTION 499 0.1099
49 CYANOPSIA 65 0.1083
50 BRAIN NATRIURETIC PEPTIDE INCREASED 331 0.1073
51 DEVICE ALARM ISSUE 192 0.1057
52 BLOOD TESTOSTERONE DECREASED 708 0.1034
53 RIGHT VENTRICULAR DILATATION 59 0.1019
54 CATHETER SITE HAEMORRHAGE 252 0.1006
55 CATHETER PLACEMENT 185 0.0997
56 INFUSION SITE SWELLING 624 0.0991
57 SCLERODERMA 358 0.0984
58 INFUSION SITE DISCOLOURATION 84 0.0955
59 INFUSION SITE NODULE 91 0.0947
60 PARACENTESIS 58 0.0943
61 SYSTEMIC SCLERODERMA 68 0.0934
62 OBSTRUCTIVE SLEEP APNOEA SYNDROME 135 0.0925
63 THERAPEUTIC RESPONSE INCREASED 84 0.0894
64 CATHETERISATION CARDIAC 395 0.0890
65 DIZZINESS EXERTIONAL 67 0.0882
66 LUNG TRANSPLANT 310 0.0875
67 INFUSION SITE RASH 120 0.0874
68 PAIN IN JAW 2462 0.0868
69 INFUSION SITE DISCOMFORT 89 0.0858
70 PULMONARY HYPERTENSION 1773 0.0850
71 INFUSION SITE PRURITUS 265 0.0839
72 MYOGLOBIN BLOOD INCREASED 126 0.0824
73 EJACULATION DELAYED 44 0.0789
74 CENTRAL VENOUS CATHETERISATION 238 0.0788
75 INFUSION SITE REACTION 222 0.0742
76 RIGHT VENTRICULAR DYSFUNCTION 79 0.0716
77 DYSPNOEA AT REST 205 0.0707
78 DERMATITIS CONTACT 767 0.0672
79 CATHETER SITE INFECTION 254 0.0671
80 DEVICE RELATED SEPSIS 135 0.0670
81 DYSPNOEA EXERTIONAL 2477 0.0657
82 HAEMATOSPERMIA 45 0.0649
83 FLUID OVERLOAD 935 0.0642
84 HYPERVOLAEMIA 315 0.0637
85 FLUID RETENTION 3225 0.0633
86 CATHETER SITE RELATED REACTION 46 0.0613
87 DEVICE RELATED INFECTION 907 0.0589
88 MALIGNANT MELANOMA 759 0.0566
89 COR PULMONALE 53 0.0555
90 DEVICE CONNECTION ISSUE 113 0.0535
91 EJACULATION FAILURE 102 0.0508
92 HAEMOGLOBIN INCREASED 228 0.0499
93 TELANGIECTASIA 48 0.0497
94 INFUSION SITE MASS 52 0.0478
95 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 66 0.0470
96 PRIAPISM 162 0.0469
97 TRANSFUSION 491 0.0468
98 URINE FLOW DECREASED 110 0.0460
99 SEASONAL ALLERGY 631 0.0445
100 INJECTION SITE INFECTION 146 0.0444
101 PENIS DISORDER 109 0.0440
102 NOCTURNAL DYSPNOEA 56 0.0439
103 ECHOCARDIOGRAM ABNORMAL 60 0.0429
104 OXYGEN THERAPY 69 0.0419
105 ERECTION INCREASED 175 0.0418
106 SUSPECTED COUNTERFEIT PRODUCT 164 0.0414
107 PLANTAR FASCIITIS 138 0.0411
108 OXYGEN SATURATION DECREASED 2239 0.0398
109 NASAL CONGESTION 2329 0.0396
110 EXERCISE TOLERANCE DECREASED 224 0.0389
111 RESPIRATION ABNORMAL 252 0.0365
112 CARDIAC ABLATION 65 0.0364
113 LEFT VENTRICULAR FAILURE 125 0.0363
114 OPTIC ISCHAEMIC NEUROPATHY 139 0.0359
115 THROMBOSIS IN DEVICE 116 0.0354
116 OXYGEN SATURATION ABNORMAL 98 0.0345
117 MIDDLE EAR EFFUSION 76 0.0344
118 ERECTILE DYSFUNCTION 875 0.0340
119 ANORGASMIA 92 0.0339
120 INFUSION SITE BRUISING 70 0.0324
121 INJECTION SITE DISCHARGE 174 0.0323
122 CARBON DIOXIDE INCREASED 44 0.0323
123 CONCOMITANT DISEASE AGGRAVATED 199 0.0322
124 DYSLIPIDAEMIA 162 0.0319
125 CARDIOVERSION 44 0.0315
126 METASTATIC MALIGNANT MELANOMA 72 0.0313
127 PURULENT DISCHARGE 133 0.0311
128 THERAPY CHANGE 306 0.0311
129 OEDEMA 1685 0.0310
130 LIVER TRANSPLANT 112 0.0308
131 DRUG TITRATION ERROR 79 0.0306
132 DEVICE POWER SOURCE ISSUE 88 0.0301
133 DEAFNESS UNILATERAL 163 0.0295
134 MECHANICAL VENTILATION 55 0.0289
135 DEVICE OCCLUSION 402 0.0285
136 LOCALISED OEDEMA 131 0.0283
137 FLUSHING 2865 0.0282
138 ACTINIC KERATOSIS 73 0.0281
139 PULMONARY PAIN 82 0.0281
140 HYPOXIA 974 0.0276
141 DIZZINESS POSTURAL 266 0.0274
142 FAECES SOFT 196 0.0269
143 EAR CONGESTION 73 0.0269
144 SUDDEN HEARING LOSS 54 0.0267
145 ATRIAL FLUTTER 211 0.0264
146 ORTHOPNOEA 84 0.0263
147 SINUS CONGESTION 348 0.0257
148 PERICARDIAL EFFUSION 591 0.0255
149 PARANASAL SINUS DISCOMFORT 93 0.0245
150 PRODUCT ADMINISTRATION INTERRUPTED 191 0.0243
151 HYPERPARATHYROIDISM SECONDARY 60 0.0239
152 CARDIAC PACEMAKER INSERTION 140 0.0235
153 ATRIAL TACHYCARDIA 48 0.0228
154 EJACULATION DISORDER 64 0.0225
155 BLOOD LOSS ANAEMIA 51 0.0225
156 ACUTE RESPIRATORY FAILURE 431 0.0224
157 DRUG TOLERANCE DECREASED 62 0.0221
158 COMPLICATION ASSOCIATED WITH DEVICE 320 0.0220
159 IRON DEFICIENCY ANAEMIA 203 0.0220
160 SYNCOPE 2178 0.0217
161 BLOOD PRESSURE SYSTOLIC DECREASED 99 0.0217
162 DYSPNOEA 12170 0.0215
163 UPPER RESPIRATORY TRACT CONGESTION 62 0.0214
164 NEPHROGENIC ANAEMIA 97 0.0209
165 HAEMOPTYSIS 569 0.0204
166 PULMONARY OEDEMA 895 0.0200
167 BREATH SOUNDS ABNORMAL 97 0.0197
168 DECREASED ACTIVITY 211 0.0195
169 PRESYNCOPE 474 0.0195
170 CARDIAC FAILURE 1562 0.0194
171 DISEASE COMPLICATION 89 0.0194
172 EPISTAXIS 1452 0.0194
173 BODY HEIGHT DECREASED 207 0.0193
174 SECRETION DISCHARGE 241 0.0192
175 THERAPEUTIC RESPONSE DELAYED 53 0.0189
176 PROSTATITIS 57 0.0187
177 BLOOD CHOLESTEROL INCREASED 873 0.0187
178 PENILE PAIN 57 0.0187
179 VASODILATATION 47 0.0186
180 BLOOD IRON DECREASED 221 0.0186
181 OEDEMA PERIPHERAL 2267 0.0186
182 SENSATION OF FOREIGN BODY 155 0.0184
183 RESPIRATORY SYNCYTIAL VIRUS INFECTION 160 0.0184
184 SINUS DISORDER 362 0.0183
185 ASCITES 536 0.0182
186 WRONG DOSE 44 0.0182
187 SINUS HEADACHE 108 0.0182
188 RHINOVIRUS INFECTION 70 0.0180
189 THERAPY NON-RESPONDER 808 0.0180
190 PRODUCTIVE COUGH 854 0.0179
191 HEADACHE 11213 0.0179
192 PROSTATOMEGALY 70 0.0178
193 TESTICULAR PAIN 56 0.0176
194 RALES 102 0.0175
195 EAR DISCOMFORT 180 0.0175
196 PNEUMONIA VIRAL 54 0.0169
197 OBSTRUCTIVE AIRWAYS DISORDER 188 0.0169
198 PORTAL HYPERTENSION 52 0.0168
199 THROAT IRRITATION 749 0.0167
200 PULMONARY CONGESTION 219 0.0166
201 NASAL DRYNESS 104 0.0166
202 RESPIRATORY TRACT CONGESTION 261 0.0164
203 BLOOD CULTURE POSITIVE 49 0.0163
204 COUGH 4578 0.0163
205 CARDIAC OPERATION 140 0.0163
206 PARANASAL SINUS HYPERSECRETION 62 0.0162
207 GOUT 291 0.0162
208 INCREASED UPPER AIRWAY SECRETION 83 0.0162
209 PNEUMOTHORAX 255 0.0161
210 DEVICE DISLOCATION 692 0.0159
211 DIALYSIS 223 0.0157
212 CARDIAC FAILURE ACUTE 104 0.0156
213 HYPOTENSION 3122 0.0155
214 BLOOD PRESSURE DECREASED 1027 0.0154
215 INTERNAL HAEMORRHAGE 176 0.0154
216 PULMONARY ALVEOLAR HAEMORRHAGE 86 0.0153
217 INFUSION SITE EXTRAVASATION 95 0.0152
218 CHEST PAIN 2762 0.0149
219 WEIGHT FLUCTUATION 156 0.0149
220 IRON DEFICIENCY 67 0.0149
221 PALPITATIONS 1731 0.0148
222 PERIPHERAL SWELLING 2269 0.0147
223 CARDIAC FLUTTER 95 0.0147
224 AORTIC STENOSIS 51 0.0146
225 INCORRECT DRUG ADMINISTRATION RATE 62 0.0146
226 NON-CARDIAC CHEST PAIN 46 0.0145
227 EMERGENCY CARE 44 0.0145
228 HEAD DISCOMFORT 255 0.0144
229 STENT PLACEMENT 116 0.0144
230 PERFORMANCE STATUS DECREASED 67 0.0143
231 HAEMORRHOIDAL HAEMORRHAGE 70 0.0143
232 HYPERCAPNIA 43 0.0143
233 UNEVALUABLE EVENT 1080 0.0143
234 CARDIOMEGALY 174 0.0141
235 THERAPEUTIC RESPONSE DECREASED 851 0.0140
236 EXOSTOSIS 128 0.0140
237 CHEST DISCOMFORT 1435 0.0140
238 AMMONIA INCREASED 71 0.0139
239 IDIOPATHIC PULMONARY FIBROSIS 55 0.0139
240 PRODUCT LEAKAGE 78 0.0139
241 CARDIAC FAILURE CONGESTIVE 1109 0.0138
242 DEVICE FAILURE 209 0.0137
243 CHOKING SENSATION 75 0.0136
244 PNEUMONIA 4359 0.0135
245 GASTROENTERITIS VIRAL 241 0.0133
246 CLOSTRIDIUM DIFFICILE INFECTION 290 0.0133
247 SUPRAVENTRICULAR TACHYCARDIA 127 0.0133
248 UPPER-AIRWAY COUGH SYNDROME 109 0.0132
249 TERMINAL STATE 88 0.0131
250 ATRIAL FIBRILLATION 1270 0.0130
251 PULMONARY HAEMORRHAGE 102 0.0130
252 HEPATIC CIRRHOSIS 245 0.0130
253 BLOOD POTASSIUM DECREASED 389 0.0129
254 CARDIAC FAILURE CHRONIC 55 0.0129
255 MYALGIA 2186 0.0128
256 DEAFNESS 334 0.0128
257 HEART RATE ABNORMAL 71 0.0127
258 DIARRHOEA 8190 0.0127
259 HOT FLUSH 950 0.0126
260 BACTERAEMIA 148 0.0125
261 MICTURITION URGENCY 142 0.0124
262 SLEEP APNOEA SYNDROME 236 0.0124
263 TRICUSPID VALVE INCOMPETENCE 98 0.0123
264 LARGE INTESTINE POLYP 85 0.0123
265 RESPIRATORY FAILURE 892 0.0122
266 VISUAL DISTURBANCE 70 0.0122
267 GASTROOESOPHAGEAL REFLUX DISEASE 981 0.0122
268 SLUGGISHNESS 123 0.0120
269 GASTRIC INFECTION 46 0.0120
270 VIRAL INFECTION 400 0.0120
271 DYSPEPSIA 1170 0.0119
272 LOCALISED INFECTION 287 0.0119
273 HEART RATE INCREASED 1175 0.0118
274 PLEURAL EFFUSION 720 0.0118
275 CARDIAC DISORDER 1105 0.0118
276 VIRAL UPPER RESPIRATORY TRACT INFECTION 56 0.0118
277 BLOOD PRESSURE ABNORMAL 234 0.0118
278 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 612 0.0117
279 LUNG DISORDER 572 0.0117
280 BACK PAIN 2701 0.0116
281 PAIN IN EXTREMITY 3424 0.0116
282 SPUTUM DISCOLOURED 109 0.0115
283 DEVICE PHYSICAL PROPERTY ISSUE 87 0.0113
284 NASOPHARYNGITIS 2081 0.0113
285 STAPHYLOCOCCAL BACTERAEMIA 49 0.0113
286 POLYURIA 92 0.0112
287 CHEMOTHERAPY 42 0.0111
288 RETINAL DETACHMENT 102 0.0111
289 URINE OUTPUT DECREASED 96 0.0110
290 SWELLING 1027 0.0110
291 CELLULITIS 552 0.0109
292 TINNITUS 503 0.0109
293 HOSPICE CARE 108 0.0109
294 ABNORMAL SENSATION IN EYE 47 0.0109
295 DIZZINESS 5452 0.0109
296 RHINORRHOEA 706 0.0109
297 GENERALISED OEDEMA 135 0.0109
298 MULTIPLE ALLERGIES 85 0.0108
299 RETCHING 231 0.0108
300 QUALITY OF LIFE DECREASED 145 0.0108
301 HEAD INJURY 342 0.0108
302 CORONARY ARTERY DISEASE 327 0.0108
303 SKIN ABRASION 51 0.0108
304 ULCER HAEMORRHAGE 73 0.0108
305 POLLAKIURIA 448 0.0107
306 ABDOMINAL DISTENSION 1121 0.0107
307 END STAGE RENAL DISEASE 194 0.0106
308 NOCTURIA 129 0.0106
309 CYANOSIS 167 0.0106
310 EYE HAEMORRHAGE 141 0.0106
311 BRONCHITIS 781 0.0105
312 HOSPITALISATION 1603 0.0104
313 BRONCHIECTASIS 70 0.0104
314 SQUAMOUS CELL CARCINOMA 97 0.0103
315 THERAPY CESSATION 526 0.0102
316 OROPHARYNGEAL DISCOMFORT 92 0.0102
317 DEVICE LEAKAGE 437 0.0101
318 VISION BLURRED 1374 0.0100
319 DEPRESSED MOOD 526 0.0099
320 VISUAL FIELD DEFECT 71 0.0098
321 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 60 0.0097
322 FOOD POISONING 52 0.0097
323 HEART RATE IRREGULAR 219 0.0097
324 TRISMUS 50 0.0097
325 LUNG INFECTION 150 0.0096
326 PULMONARY FIBROSIS 185 0.0096
327 UPPER RESPIRATORY TRACT INFECTION 445 0.0096
328 FLANK PAIN 90 0.0096
329 PNEUMONIA BACTERIAL 88 0.0096
330 NASAL DISCOMFORT 76 0.0096
331 MUSCULOSKELETAL CHEST PAIN 148 0.0096
332 OROPHARYNGEAL PAIN 883 0.0095
333 GASTROINTESTINAL MOTILITY DISORDER 51 0.0095
334 MEDICAL DEVICE COMPLICATION 70 0.0095
335 WHEEZING 560 0.0094
336 BLOOD COUNT ABNORMAL 143 0.0094
337 LOSS OF CONSCIOUSNESS 1206 0.0094
338 NECK PAIN 524 0.0094
339 THERAPY INTERRUPTED 670 0.0094
340 INFLUENZA 1041 0.0093
341 RESPIRATORY DISTRESS 254 0.0092
342 RESTLESS LEGS SYNDROME 167 0.0092
343 INTENTIONAL DOSE OMISSION 261 0.0091
344 ASTHENIA 3432 0.0091
345 ANAL INCONTINENCE 82 0.0091
346 STAPHYLOCOCCAL INFECTION 299 0.0091
347 ABDOMINAL DISCOMFORT 1520 0.0091
348 EAR INFECTION 241 0.0090
349 SARCOIDOSIS 43 0.0090
350 DIABETES MELLITUS 688 0.0090
351 NO THERAPEUTIC RESPONSE 110 0.0090
352 FEELING COLD 251 0.0090
353 LOSS OF LIBIDO 81 0.0090
354 FAECES DISCOLOURED 195 0.0090
355 BASAL CELL CARCINOMA 140 0.0090
356 ENDOCARDITIS 46 0.0090
357 ANAEMIA 1695 0.0089
358 BOWEL MOVEMENT IRREGULARITY 68 0.0089
359 MALAISE 3852 0.0088
360 BLINDNESS UNILATERAL 123 0.0087
361 DYSPHONIA 510 0.0087
362 PULMONARY THROMBOSIS 95 0.0087
363 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 53 0.0087
364 RENAL DISORDER 405 0.0087
365 HYPOACUSIS 374 0.0087
366 DIABETIC NEUROPATHY 43 0.0087
367 BLINDNESS TRANSIENT 64 0.0087
368 FEELING ABNORMAL 2068 0.0086
369 NAUSEA 6829 0.0086
370 TREATMENT NONCOMPLIANCE 470 0.0086
371 MIGRAINE 819 0.0086
372 CARDIAC VALVE DISEASE 49 0.0086
373 GASTROINTESTINAL HAEMORRHAGE 713 0.0085
374 HIP FRACTURE 273 0.0085
375 SLEEP DISORDER 599 0.0085
376 MUSCULOSKELETAL DISCOMFORT 146 0.0085
377 RESPIRATORY TRACT INFECTION 220 0.0084
378 MUSCLE STRAIN 73 0.0084
379 SINUSITIS 864 0.0084
380 CATARACT OPERATION 50 0.0084
381 PROSTATIC SPECIFIC ANTIGEN INCREASED 116 0.0084
382 PHOTOPSIA 53 0.0084
383 WEIGHT DECREASED 2326 0.0083
384 RHINITIS 67 0.0083
385 HAEMORRHOIDS 162 0.0083
386 EAR PAIN 161 0.0083
387 RESPIRATORY DISORDER 247 0.0082
388 EOSINOPHILIA 144 0.0082
389 MUSCULOSKELETAL PAIN 430 0.0082
390 LACERATION 77 0.0082
391 TOOTHACHE 148 0.0082
392 BLOOD PRESSURE DIASTOLIC DECREASED 60 0.0081
393 SKIN INFECTION 91 0.0081
394 SUBDURAL HAEMATOMA 116 0.0081
395 BRAIN FOG 127 0.0081
396 HAEMATOCRIT DECREASED 160 0.0081
397 LIMB INJURY 219 0.0081
398 GASTRIC DISORDER 276 0.0080
399 HYPERTENSION 1703 0.0080
400 FULL BLOOD COUNT ABNORMAL 85 0.0080
401 RIB FRACTURE 165 0.0080
402 DIVERTICULUM 57 0.0080
403 HERNIA 155 0.0080
404 FATIGUE 6241 0.0080
405 THERAPY PARTIAL RESPONDER 125 0.0080
406 HAEMODYNAMIC INSTABILITY 61 0.0080
407 JOINT INJURY 171 0.0080
408 HAEMOGLOBIN DECREASED 821 0.0080
409 APPETITE DISORDER 53 0.0080
410 DECREASED APPETITE 1856 0.0080
411 POLYP 52 0.0079
412 OCULAR DISCOMFORT 89 0.0079
413 MOUTH HAEMORRHAGE 58 0.0079
414 BACK INJURY 86 0.0079
415 FREQUENT BOWEL MOVEMENTS 213 0.0079
416 KIDNEY INFECTION 154 0.0078
417 CARDIOGENIC SHOCK 112 0.0078
418 COVID-19 PNEUMONIA 92 0.0078
419 CHRONIC KIDNEY DISEASE 590 0.0078
420 GASTRIC HAEMORRHAGE 89 0.0077
421 NEURALGIA 188 0.0077
422 VITREOUS FLOATERS 76 0.0077
423 FACIAL PAIN 69 0.0077
424 LIMB DISCOMFORT 239 0.0077
425 HEPATIC ENCEPHALOPATHY 72 0.0077
426 PELVIC FRACTURE 60 0.0077
427 CHOLECYSTECTOMY 88 0.0077
428 GALLBLADDER DISORDER 137 0.0077
429 DRY THROAT 78 0.0077
430 ACUTE PULMONARY OEDEMA 43 0.0077
431 RENAL FAILURE 1017 0.0077
432 SUDDEN DEATH 81 0.0076
433 VOMITING 3587 0.0076
434 PERIORBITAL SWELLING 43 0.0076
435 FLATULENCE 431 0.0076
436 EXTRASYSTOLES 53 0.0076
437 SKIN LACERATION 82 0.0075
438 VISUAL IMPAIRMENT 934 0.0075
439 DEHYDRATION 1003 0.0075
440 SEPSIS 836 0.0075
441 HEART RATE DECREASED 263 0.0075
442 SWELLING OF EYELID 47 0.0075
443 LIGAMENT SPRAIN 74 0.0075
444 FEELING HOT 457 0.0074
445 WEIGHT INCREASED 1664 0.0074
446 PRODUCT DOSE OMISSION 484 0.0074
447 MUSCLE SPASMS 1359 0.0074
448 ATRIAL SEPTAL DEFECT 62 0.0074
449 SCIATICA 118 0.0074
450 SNEEZING 166 0.0074
451 GASTROENTERITIS 108 0.0074
452 OCULAR HYPERAEMIA 351 0.0074
453 POOR QUALITY SLEEP 159 0.0074
454 VISUAL ACUITY REDUCED 245 0.0074
455 ERUCTATION 142 0.0073
456 GINGIVAL BLEEDING 100 0.0073
457 GASTROINTESTINAL DISORDER 654 0.0073
458 ABDOMINAL PAIN UPPER 1498 0.0073
459 CLOSTRIDIUM DIFFICILE COLITIS 77 0.0073
460 ATELECTASIS 70 0.0072
461 INTERSTITIAL LUNG DISEASE 350 0.0072
462 HAEMATEMESIS 182 0.0072
463 ELECTROLYTE IMBALANCE 83 0.0071
464 HIATUS HERNIA 92 0.0071
465 TRANSIENT ISCHAEMIC ATTACK 239 0.0071
466 DEATH 6069 0.0070
467 HYPERSOMNIA 201 0.0070
468 HIP ARTHROPLASTY 107 0.0070
469 FALL 2321 0.0070
470 BEDRIDDEN 91 0.0069
471 CHILLS 809 0.0069
472 BACTERIAL INFECTION 128 0.0069
473 EYE SWELLING 255 0.0068
474 LACRIMATION INCREASED 207 0.0068
475 BLOOD MAGNESIUM DECREASED 59 0.0068
476 GROIN PAIN 60 0.0068
477 SEXUAL DYSFUNCTION 80 0.0068
478 CONDITION AGGRAVATED 2068 0.0068
479 BACK DISORDER 110 0.0068
480 INTENTIONAL PRODUCT MISUSE 592 0.0068
481 SPINAL OPERATION 83 0.0067
482 HYPERCHOLESTEROLAEMIA 65 0.0067
483 BRONCHOSPASM 96 0.0067
484 SURGERY 394 0.0067
485 SMALL INTESTINAL OBSTRUCTION 82 0.0067
486 CORONAVIRUS INFECTION 44 0.0066
487 EMPHYSEMA 67 0.0066
488 DRUG DOSE OMISSION 1096 0.0066
489 INJECTION SITE IRRITATION 84 0.0066
490 BLOOD POTASSIUM INCREASED 107 0.0066
491 DYSURIA 242 0.0066
492 TROPONIN INCREASED 50 0.0066
493 CEREBRAL HAEMORRHAGE 235 0.0066
494 POST PROCEDURAL COMPLICATION 126 0.0066
495 PERIPHERAL COLDNESS 90 0.0065
496 DEVICE ISSUE 586 0.0065
497 LYMPHOEDEMA 45 0.0065
498 SPLENOMEGALY 76 0.0065
499 MUSCLE TIGHTNESS 105 0.0065
500 RED BLOOD CELL COUNT DECREASED 185 0.0065
501 PHARYNGITIS STREPTOCOCCAL 70 0.0065
502 HYSTERECTOMY 56 0.0065
503 DIVERTICULITIS 179 0.0065
504 HICCUPS 53 0.0065
505 ROAD TRAFFIC ACCIDENT 270 0.0064
506 COLON CANCER 96 0.0064
507 AORTIC ANEURYSM 49 0.0064
508 SARS-COV-2 TEST POSITIVE 85 0.0064
509 SPINAL COMPRESSION FRACTURE 53 0.0064
510 PROCEDURAL COMPLICATION 49 0.0064
511 RECTAL HAEMORRHAGE 274 0.0064
512 PULMONARY MASS 95 0.0064
513 EYE INFECTION 72 0.0064
514 TOOTH INFECTION 84 0.0064
515 HAEMATOCHEZIA 350 0.0063
516 CONCUSSION 49 0.0063
517 SWELLING FACE 410 0.0063
518 DRUG INTOLERANCE 608 0.0063
519 HYPERTHYROIDISM 91 0.0063
520 TOOTH ABSCESS 64 0.0063
521 PALLOR 171 0.0063
522 UPPER LIMB FRACTURE 125 0.0063
523 PHOTOPHOBIA 118 0.0063
524 TACHYCARDIA 557 0.0063
525 ECONOMIC PROBLEM 95 0.0063
526 INTRAOCULAR PRESSURE INCREASED 80 0.0063
527 AUTOIMMUNE DISORDER 61 0.0063
528 GASTROINTESTINAL INFECTION 56 0.0062
529 MENTAL STATUS CHANGES 173 0.0062
530 SCAB 71 0.0062
531 NEPHROPATHY 58 0.0062
532 ASPIRATION 68 0.0062
533 INTERNATIONAL NORMALISED RATIO INCREASED 177 0.0062
534 CORONARY ARTERY OCCLUSION 85 0.0062
535 MACULAR DEGENERATION 74 0.0062
536 LETHARGY 356 0.0062
537 POST PROCEDURAL HAEMORRHAGE 72 0.0062
538 PRODUCT DISTRIBUTION ISSUE 57 0.0061
539 ARRHYTHMIA 291 0.0061
540 INITIAL INSOMNIA 63 0.0061
541 ANKLE FRACTURE 95 0.0061
542 RENAL PAIN 65 0.0061
543 CARDIAC ARREST 504 0.0061
544 KNEE OPERATION 60 0.0061
545 APHONIA 85 0.0061
546 SUBARACHNOID HAEMORRHAGE 62 0.0061
547 DISEASE PROGRESSION 720 0.0061
548 INSOMNIA 1614 0.0061
549 SYSTEMIC LUPUS ERYTHEMATOSUS 215 0.0061
550 EYE DISORDER 199 0.0060
551 UNINTENTIONAL MEDICAL DEVICE REMOVAL 70 0.0060
552 URINARY TRACT INFECTION 1032 0.0060
553 RENAL IMPAIRMENT 508 0.0060
554 ILLNESS 622 0.0060
555 RETINAL HAEMORRHAGE 43 0.0060
556 ANGINA PECTORIS 172 0.0060
557 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 425 0.0060
558 JOINT SWELLING 718 0.0059
559 BLOOD SODIUM DECREASED 112 0.0059
560 BLADDER DISORDER 59 0.0059
561 THROMBOSIS 477 0.0059
562 HEPATOMEGALY 58 0.0059
563 BLOOD PRESSURE FLUCTUATION 141 0.0059
564 ORTHOSTATIC HYPOTENSION 102 0.0059
565 DIPLOPIA 152 0.0058
566 PNEUMONIA ASPIRATION 146 0.0058
567 CATARACT 348 0.0058
568 DEVICE USE ERROR 203 0.0058
569 BLOOD ALKALINE PHOSPHATASE INCREASED 145 0.0058
570 PYREXIA 2015 0.0058
571 COLD SWEAT 102 0.0058
572 HAEMORRHAGE 605 0.0058
573 TOOTH EXTRACTION 72 0.0058
574 POST PROCEDURAL INFECTION 47 0.0058
575 MELAENA 127 0.0058
576 INFLUENZA LIKE ILLNESS 473 0.0057
577 LIVER DISORDER 253 0.0057
578 ARTHRALGIA 2361 0.0057
579 HAEMORRHAGIC STROKE 44 0.0056
580 MALNUTRITION 63 0.0056
581 INFECTION 815 0.0056
582 ARTHRITIS 442 0.0056
583 BLOOD DISORDER 45 0.0056
584 PAIN 3448 0.0056
585 HYPERAESTHESIA 46 0.0056
586 ARTERIAL OCCLUSIVE DISEASE 44 0.0056
587 VENTRICULAR FIBRILLATION 62 0.0056
588 BLINDNESS 227 0.0056
589 TASTE DISORDER 113 0.0056
590 EYE PAIN 313 0.0055
591 ISCHAEMIC STROKE 99 0.0055
592 UNRESPONSIVE TO STIMULI 143 0.0055
593 CHOLECYSTITIS 66 0.0055
594 VENTRICULAR TACHYCARDIA 91 0.0055
595 COVID-19 965 0.0055
596 CONSTIPATION 1197 0.0055
597 ANHEDONIA 144 0.0055
598 UPPER GASTROINTESTINAL HAEMORRHAGE 92 0.0055
599 APPENDICITIS 51 0.0055
600 GLAUCOMA 105 0.0054
601 TACHYPNOEA 74 0.0054
602 BLOOD URINE PRESENT 103 0.0054
603 PLATELET COUNT DECREASED 578 0.0054
604 EXTRA DOSE ADMINISTERED 219 0.0054
605 GINGIVAL PAIN 43 0.0054
606 NIGHT SWEATS 174 0.0054
607 IMPAIRED GASTRIC EMPTYING 73 0.0053
608 DEVICE BREAKAGE 217 0.0053
609 WRIST FRACTURE 64 0.0053
610 DRY MOUTH 433 0.0053
611 EYELID OEDEMA 62 0.0053
612 ABDOMINAL PAIN 1237 0.0053
613 NERVE COMPRESSION 49 0.0053
614 LOWER LIMB FRACTURE 102 0.0053
615 CHOLELITHIASIS 174 0.0053
616 GLOMERULAR FILTRATION RATE DECREASED 65 0.0053
617 DECUBITUS ULCER 43 0.0053
618 ABSCESS 84 0.0053
619 VITAMIN D DECREASED 45 0.0053
620 INSURANCE ISSUE 80 0.0052
621 KNEE ARTHROPLASTY 110 0.0052
622 BLOOD BILIRUBIN INCREASED 141 0.0052
623 OESOPHAGITIS 57 0.0052
624 ARTERIOSCLEROSIS 49 0.0052
625 UROSEPSIS 48 0.0052
626 HYPOKALAEMIA 238 0.0052
627 DEVICE MALFUNCTION 361 0.0051
628 BLOOD UREA INCREASED 86 0.0051
629 MUSCLE ATROPHY 65 0.0051
630 FEEDING DISORDER 104 0.0051
631 BLOOD TEST ABNORMAL 72 0.0051
632 BONE PAIN 300 0.0051
633 ACCIDENT 61 0.0051
634 FACE OEDEMA 86 0.0051
635 FEELING JITTERY 97 0.0051
636 INTERVERTEBRAL DISC DEGENERATION 47 0.0051
637 PHARYNGITIS 63 0.0051
638 ACUTE KIDNEY INJURY 777 0.0051
639 ANXIETY 1444 0.0051
640 SKIN ULCER 131 0.0051
641 SEPTIC SHOCK 220 0.0051
642 INTESTINAL OBSTRUCTION 190 0.0050
643 CANDIDA INFECTION 85 0.0050
644 ACCIDENTAL OVERDOSE 184 0.0050
645 HYPERLIPIDAEMIA 60 0.0050
646 DEPRESSION 1140 0.0050
647 BRAIN INJURY 50 0.0050
648 ACUTE MYOCARDIAL INFARCTION 147 0.0050
649 LIVER FUNCTION TEST INCREASED 107 0.0050
650 ROTATOR CUFF SYNDROME 64 0.0050
651 BLOOD CREATININE INCREASED 325 0.0050
652 SPINAL FRACTURE 99 0.0049
653 BALANCE DISORDER 427 0.0049
654 THYROID DISORDER 76 0.0049
655 MUSCULAR WEAKNESS 558 0.0049
656 ASPARTATE AMINOTRANSFERASE INCREASED 259 0.0049
657 MIDDLE INSOMNIA 90 0.0048
658 GASTROINTESTINAL PAIN 53 0.0048
659 GENERAL PHYSICAL HEALTH DETERIORATION 555 0.0048
660 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 230 0.0048
661 ULCER 76 0.0048
662 MITRAL VALVE INCOMPETENCE 54 0.0048
663 RASH PRURITIC 258 0.0048
664 WOUND 133 0.0048
665 GASTRITIS 124 0.0047
666 NEPHROLITHIASIS 216 0.0047
667 VERTIGO 285 0.0047
668 CARDIO-RESPIRATORY ARREST 195 0.0047
669 TEMPERATURE INTOLERANCE 48 0.0046
670 CHROMATURIA 105 0.0046
671 FOOT FRACTURE 88 0.0046
672 INJECTION SITE INDURATION 60 0.0046
673 CONTUSION 443 0.0046
674 SKIN DISCOLOURATION 211 0.0046
675 SOMNOLENCE 924 0.0046
676 CYSTITIS 146 0.0046
677 MULTIPLE ORGAN DYSFUNCTION SYNDROME 129 0.0045
678 BLOOD PRESSURE INCREASED 693 0.0045
679 GAIT DISTURBANCE 867 0.0045
680 ILEUS 56 0.0045
681 BREAST PAIN 48 0.0045
682 URINARY RETENTION 150 0.0045
683 ERYTHEMA 922 0.0045
684 HEPATIC FUNCTION ABNORMAL 167 0.0045
685 THROAT TIGHTNESS 121 0.0045
686 GAMMA-GLUTAMYLTRANSFERASE INCREASED 99 0.0045
687 BODY TEMPERATURE INCREASED 91 0.0045
688 INCONTINENCE 47 0.0044
689 LYMPHADENOPATHY 157 0.0044
690 OSTEOMYELITIS 80 0.0044
691 ORAL CANDIDIASIS 58 0.0044
692 LUNG NEOPLASM MALIGNANT 181 0.0044
693 URINARY INCONTINENCE 130 0.0044
694 NERVOUSNESS 229 0.0044
695 GAIT INABILITY 146 0.0044
696 PRODUCT USE ISSUE 819 0.0044
697 HEPATIC FAILURE 131 0.0043
698 HYPERHIDROSIS 557 0.0043
699 MEMORY IMPAIRMENT 593 0.0043
700 MOOD ALTERED 117 0.0043
701 DEVICE USE ISSUE 75 0.0043
702 PANCREATITIS 226 0.0043
703 PRODUCT DOSE OMISSION IN ERROR 121 0.0043
704 DRUG INEFFECTIVE 5626 0.0043
705 GASTRIC ULCER 81 0.0043
706 PRODUCT USE COMPLAINT 67 0.0042
707 LABORATORY TEST ABNORMAL 125 0.0042
708 HERPES ZOSTER 243 0.0042
709 OSTEOPENIA 64 0.0042
710 CHOKING 82 0.0042
711 THIRST 75 0.0042
712 TOOTH DISORDER 93 0.0042
713 PRODUCT DOSE OMISSION ISSUE 1225 0.0042
714 ORAL PAIN 93 0.0041
715 LIP SWELLING 138 0.0041
716 VENTRICULAR EXTRASYSTOLES 43 0.0041
717 WRONG TECHNIQUE IN DRUG USAGE PROCESS 150 0.0041
718 FULL BLOOD COUNT DECREASED 83 0.0041
719 PULMONARY EMBOLISM 391 0.0041
720 SCRATCH 43 0.0041
721 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 825 0.0041
722 MYOCARDIAL ISCHAEMIA 46 0.0040
723 HYPOAESTHESIA 604 0.0040
724 MYOCARDIAL INFARCTION 703 0.0040
725 CYST 50 0.0040
726 INTERVERTEBRAL DISC PROTRUSION 88 0.0040
727 DRUG INTERACTION 638 0.0040
728 INTENTIONAL DRUG MISUSE 84 0.0040
729 BLOOD GLUCOSE FLUCTUATION 44 0.0040
730 SKIN IRRITATION 183 0.0040
731 DENTAL CARIES 44 0.0040
732 ADVERSE EVENT 366 0.0040
733 EXPIRED PRODUCT ADMINISTERED 132 0.0040
734 CEREBROVASCULAR ACCIDENT 671 0.0040
735 FUNGAL INFECTION 132 0.0040
736 HYPOPHAGIA 101 0.0039
737 DISCOMFORT 241 0.0039
738 HAEMORRHAGE INTRACRANIAL 59 0.0039
739 NEOPLASM MALIGNANT 263 0.0039
740 RENAL INJURY 117 0.0039
741 HAEMATOMA 102 0.0039
742 CIRCULATORY COLLAPSE 67 0.0039
743 CONFUSIONAL STATE 633 0.0039
744 DEMENTIA 109 0.0039
745 SKIN DISORDER 130 0.0039
746 AGEUSIA 97 0.0039
747 AMNESIA 252 0.0039
748 NERVE INJURY 43 0.0039
749 ALANINE AMINOTRANSFERASE INCREASED 235 0.0038
750 COLITIS 145 0.0038
751 IRRITABLE BOWEL SYNDROME 82 0.0038
752 BLOOD CALCIUM DECREASED 43 0.0038
753 DYSSTASIA 111 0.0038
754 PARAESTHESIA 597 0.0038
755 CARPAL TUNNEL SYNDROME 53 0.0038
756 DYSPHAGIA 359 0.0038
757 HAEMATURIA 129 0.0038
758 PANIC ATTACK 137 0.0038
759 HEPATIC STEATOSIS 70 0.0038
760 BLOOD GLUCOSE ABNORMAL 69 0.0037
761 RASH MACULAR 130 0.0037
762 LIVER FUNCTION TEST ABNORMAL 108 0.0037
763 HYPERSENSITIVITY 684 0.0037
764 PRESCRIBED OVERDOSE 71 0.0037
765 LOCAL SWELLING 64 0.0037
766 OFF LABEL USE 3210 0.0037
767 APATHY 53 0.0036
768 TENDONITIS 56 0.0036
769 NEUROPATHY PERIPHERAL 344 0.0036
770 WHITE BLOOD CELL COUNT INCREASED 138 0.0036
771 PRODUCT SUBSTITUTION ISSUE 207 0.0036
772 BURNING SENSATION 250 0.0036
773 ACUTE RESPIRATORY DISTRESS SYNDROME 63 0.0036
774 PROSTATE CANCER 286 0.0036
775 NODULE 46 0.0035
776 TREMOR 583 0.0035
777 MASS 49 0.0035
778 CARDIOVASCULAR DISORDER 89 0.0035
779 OSTEOPOROSIS 144 0.0035
780 HEMIPARESIS 59 0.0035
781 HYPERCALCAEMIA 43 0.0035
782 BLISTER 195 0.0035
783 RASH ERYTHEMATOUS 165 0.0034
784 RESPIRATORY ARREST 95 0.0034
785 SCAR 59 0.0034
786 MUSCULOSKELETAL STIFFNESS 301 0.0034
787 SHOCK 79 0.0034
788 DYSGEUSIA 254 0.0034
789 RASH 1481 0.0034
790 MENTAL IMPAIRMENT 82 0.0034
791 SENSORY DISTURBANCE 54 0.0034
792 LOWER RESPIRATORY TRACT INFECTION 153 0.0034
793 APPLICATION SITE PRURITUS 76 0.0033
794 DELIRIUM 116 0.0033
795 CONJUNCTIVITIS 62 0.0033
796 PANCREATITIS ACUTE 75 0.0033
797 DRY EYE 166 0.0033
798 HYPOAESTHESIA ORAL 50 0.0033
799 MOBILITY DECREASED 238 0.0033
800 CARDIOMYOPATHY 48 0.0032
801 EATING DISORDER 69 0.0032
802 JOINT STIFFNESS 85 0.0032
803 LYMPHOMA 50 0.0032
804 BLOOD GLUCOSE DECREASED 155 0.0032
805 RESTLESSNESS 118 0.0032
806 ASTHMA 363 0.0032
807 ADVERSE DRUG REACTION 288 0.0032
808 INJECTION SITE RASH 98 0.0032
809 EYE PRURITUS 107 0.0032
810 OSTEOARTHRITIS 135 0.0032
811 PHOTOSENSITIVITY REACTION 52 0.0031
812 HYPONATRAEMIA 177 0.0031
813 TUBULOINTERSTITIAL NEPHRITIS 58 0.0031
814 INCREASED APPETITE 59 0.0031
815 MEDICATION ERROR 171 0.0031
816 PRODUCT ADMINISTRATION ERROR 62 0.0031
817 FEMUR FRACTURE 95 0.0031
818 INTENTIONAL PRODUCT USE ISSUE 267 0.0030
819 SKIN HAEMORRHAGE 45 0.0030
820 INJECTION SITE ERYTHEMA 376 0.0030
821 HYPOKINESIA 44 0.0030
822 INFLAMMATION 156 0.0030
823 OBESITY 48 0.0030
824 COAGULOPATHY 50 0.0030
825 PRURITUS 1148 0.0030
826 PARAESTHESIA ORAL 43 0.0030
827 APHASIA 90 0.0030
828 INTENTIONAL OVERDOSE 190 0.0030
829 UNDERDOSE 215 0.0029
830 PNEUMONITIS 80 0.0029
831 HYPERKALAEMIA 103 0.0029
832 DRUG ERUPTION 52 0.0029
833 LEUKOCYTOSIS 53 0.0029
834 EYE IRRITATION 168 0.0029
835 DISORIENTATION 115 0.0029
836 ANOSMIA 42 0.0029
837 MOVEMENT DISORDER 93 0.0029
838 HYPOTHYROIDISM 92 0.0029
839 DEVICE ADHESION ISSUE 44 0.0029
840 JAUNDICE 77 0.0029
841 MENORRHAGIA 56 0.0028
842 ENCEPHALOPATHY 70 0.0028
843 ILL-DEFINED DISORDER 173 0.0028
844 SPEECH DISORDER 149 0.0028
845 INCORRECT DOSE ADMINISTERED 648 0.0028
846 INJECTION SITE PRURITUS 187 0.0028
847 DEEP VEIN THROMBOSIS 181 0.0028
848 PARANOIA 48 0.0028
849 HYPOGLYCAEMIA 134 0.0028
850 DRUG PRESCRIBING ERROR 53 0.0028
851 PREGNANCY 55 0.0027
852 IRRITABILITY 165 0.0027
853 PRURITUS GENERALISED 59 0.0027
854 PANCYTOPENIA 152 0.0027
855 PROCEDURAL PAIN 75 0.0027
856 SEIZURE 312 0.0027
857 PERICARDITIS 45 0.0027
858 GENERALISED TONIC-CLONIC SEIZURE 44 0.0027
859 SKIN CANCER 57 0.0026
860 ABNORMAL DREAMS 73 0.0026
861 BRADYCARDIA 140 0.0026
862 FIBROMYALGIA 64 0.0026
863 WHITE BLOOD CELL COUNT DECREASED 285 0.0026
864 CEREBRAL INFARCTION 64 0.0026
865 METASTASES TO LIVER 46 0.0026
866 BLOOD PRESSURE SYSTOLIC INCREASED 51 0.0026
867 DISTURBANCE IN ATTENTION 141 0.0026
868 ABDOMINAL PAIN LOWER 66 0.0026
869 RASH GENERALISED 67 0.0026
870 DRUG-INDUCED LIVER INJURY 81 0.0026
871 METABOLIC ACIDOSIS 82 0.0026
872 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 182 0.0026
873 SKIN LESION 70 0.0025
874 DYSARTHRIA 96 0.0025
875 FRACTURE 48 0.0025
876 INJECTION SITE HAEMORRHAGE 202 0.0025
877 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 452 0.0025
878 MENTAL DISORDER 109 0.0025
879 IMPAIRED HEALING 82 0.0025
880 URTICARIA 418 0.0025
881 THROMBOCYTOPENIA 278 0.0025
882 INJECTION SITE SWELLING 189 0.0025
883 ANGER 83 0.0025
884 MUSCLE TWITCHING 56 0.0024
885 ABASIA 60 0.0024
886 VAGINAL HAEMORRHAGE 105 0.0024
887 THERAPEUTIC RESPONSE UNEXPECTED 108 0.0024
888 EMOTIONAL DISORDER 74 0.0024
889 PRODUCT PHYSICAL ISSUE 48 0.0024
890 C-REACTIVE PROTEIN INCREASED 85 0.0023
891 RASH PAPULAR 52 0.0023
892 THINKING ABNORMAL 43 0.0023
893 SWOLLEN TONGUE 72 0.0023
894 SKIN FISSURES 45 0.0023
895 BONE DENSITY DECREASED 72 0.0023
896 CHOLESTASIS 44 0.0023
897 MOOD SWINGS 73 0.0023
898 PRODUCT AVAILABILITY ISSUE 52 0.0023
899 GLOSSODYNIA 51 0.0023
900 INJECTION SITE WARMTH 46 0.0022
901 HEPATIC ENZYME INCREASED 152 0.0022
902 NIGHTMARE 77 0.0022
903 GLYCOSYLATED HAEMOGLOBIN INCREASED 56 0.0022
904 EMOTIONAL DISTRESS 265 0.0022
905 COMA 103 0.0022
906 DRUG EFFECT DECREASED 115 0.0021
907 ACTIVITIES OF DAILY LIVING IMPAIRED 42 0.0021
908 FEAR 57 0.0021
909 DYSKINESIA 86 0.0021
910 EXPOSURE DURING PREGNANCY 130 0.0021
911 AGITATION 152 0.0021
912 ARTHROPATHY 115 0.0021
913 ECZEMA 107 0.0020
914 APPLICATION SITE PAIN 45 0.0020
915 OVERDOSE 437 0.0020
916 CONTRAINDICATED PRODUCT ADMINISTERED 61 0.0020
917 COGNITIVE DISORDER 94 0.0020
918 INJECTION SITE PAIN 617 0.0020
919 DRY SKIN 268 0.0020
920 GYNAECOMASTIA 62 0.0020
921 TRANSAMINASES INCREASED 44 0.0020
922 PREMATURE BABY 59 0.0020
923 RENAL FAILURE ACUTE 83 0.0020
924 CRYING 70 0.0019
925 ANGIOEDEMA 85 0.0019
926 HEPATIC CANCER 46 0.0019
927 INCORRECT DOSE ADMINISTERED BY DEVICE 50 0.0019
928 DEPRESSED LEVEL OF CONSCIOUSNESS 75 0.0019
929 DRUG ADMINISTRATION ERROR 58 0.0019
930 ABNORMAL BEHAVIOUR 74 0.0019
931 DRUG ABUSE 155 0.0019
932 SKIN EXFOLIATION 156 0.0018
933 LIVER INJURY 45 0.0018
934 HALLUCINATION 138 0.0018
935 BLOOD GLUCOSE INCREASED 344 0.0018
936 TYPE 2 DIABETES MELLITUS 61 0.0018
937 HYPERGLYCAEMIA 66 0.0018
938 APPLICATION SITE ERYTHEMA 47 0.0018
939 PSORIATIC ARTHROPATHY 72 0.0018
940 EPILEPSY 54 0.0018
941 DRUG EFFECT INCOMPLETE 64 0.0018
942 INJURY 123 0.0017
943 DISEASE RECURRENCE 83 0.0017
944 BLOOD CREATINE PHOSPHOKINASE INCREASED 49 0.0017
945 AGGRESSION 85 0.0017
946 PLASMA CELL MYELOMA 64 0.0016
947 STOMATITIS 99 0.0016
948 THERAPEUTIC PRODUCT EFFECT DECREASED 73 0.0016
949 PANCREATIC CARCINOMA 47 0.0016
950 EXPOSURE VIA SKIN CONTACT 42 0.0016
951 SUICIDAL IDEATION 141 0.0015
952 COMPLETED SUICIDE 125 0.0015
953 INJECTION SITE MASS 54 0.0015
954 COLITIS ULCERATIVE 65 0.0015
955 CONVULSION 81 0.0014
956 DEVICE DIFFICULT TO USE 93 0.0014
957 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 65 0.0014
958 TOXICITY TO VARIOUS AGENTS 232 0.0014
959 ALOPECIA 269 0.0014
960 INJECTION SITE BRUISING 109 0.0014
961 ELECTROCARDIOGRAM QT PROLONGED 49 0.0014
962 MATERNAL EXPOSURE DURING PREGNANCY 119 0.0013
963 PRODUCT USE IN UNAPPROVED INDICATION 326 0.0013
964 RHEUMATOID ARTHRITIS 144 0.0013
965 BREAST CANCER 118 0.0013
966 PSORIASIS 164 0.0013
967 ANAPHYLACTIC REACTION 67 0.0012
968 ACNE 91 0.0012
969 INJECTION SITE REACTION 82 0.0012
970 LEUKOPENIA 59 0.0012
971 NEUTROPENIA 159 0.0012
972 RHABDOMYOLYSIS 48 0.0011
973 WITHDRAWAL SYNDROME 48 0.0011
974 TREATMENT FAILURE 94 0.0011
975 INFUSION RELATED REACTION 75 0.0011
976 BLADDER CANCER 65 0.0011
977 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 60 0.0011
978 MULTIPLE SCLEROSIS 48 0.0010
979 PRODUCT QUALITY ISSUE 136 0.0010
980 RENAL CANCER 47 0.0010
981 ACCIDENTAL EXPOSURE TO PRODUCT 99 0.0010
982 DERMATITIS ATOPIC 49 0.0009
983 NO ADVERSE EVENT 158 0.0009
984 MULTIPLE SCLEROSIS RELAPSE 59 0.0009
985 SKIN BURNING SENSATION 61 0.0009
986 SUICIDE ATTEMPT 47 0.0008
987 DRUG WITHDRAWAL SYNDROME 65 0.0007
988 FOETAL EXPOSURE DURING PREGNANCY 50 0.0006
989 MALIGNANT NEOPLASM PROGRESSION 62 0.0006
990 DRUG DEPENDENCE 64 0.0004